Radar · Life Sciences in Ontario
Best Life Sciences Companies in Ontario, Canada
The 674 best Life Sciences companies in Ontario, Canada in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: ProMIS Neurosciences.
By Riya SenguptaFinancials
674companies tracked
$3.9Bdisclosed funding
0unicorns
242have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × ONTARIO
Our analysis of 50 Life Sciences companies
$27.5b in tracked funding; 76% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
50companies analysed
76%cloud-native stacks
2025funding peak (by rounds)
2013median founding year
45median Fliar Index™
339kcombined LinkedIn audience
36%of audience held by top 3
6companies hiring publicly (12 mo)
Ranked: Best Life Sciences companies in Ontario
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | ProMIS Neurosciences Antibody therapeutics and diagnostics for neurodegenerative diseases 37Funding top 10%Patents top 38%Moat top 38%Talent top 38% All 9 signals ▾Fundingtop 10% Patentstop 38% Moattop 38% Talenttop 38% Newstop 42% Innovationtop 47% Globalbottom 48% Techbottom 34% Marketbottom 24% Funding: Raised $247M across 37 rounds · 37 rounds over 20 yrs (1.9/yr) Patents: 78 patents matched (strict assignee match) · 29 filings since 2022 vs 39 in 2017-21 rank vs industry peers · Fliar Intelligence Index 37/100 | $247M | 4 mo ago | 7 | Neil Cashman Co-Founder | BootstrapApache HTTP ServerjQuery+10 | 78 patents Therapeutic antibodies targeting misfolded neurodegenerative proteins (TDP-43, α‑synuclein, Aβ, SOD1). | — |
| 2 | Deep Genomics AI-powered platform for RNA biology to accelerate genetic therapy discovery 55AI top 22%Moat top 28%Funding top 29%Patents top 33% All 11 signals ▾AItop 22% Moattop 28% Fundingtop 29% Patentstop 33% Innovationtop 39% Talenttop 41% Marketbottom 49% Globalbottom 43% Techbottom 37% Growthbottom 35% Newsbottom 27% AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) Moat: Editorial + unicorn rating 8/10 · IP moat: 92 patents rank vs industry peers · Fliar Intelligence Index 55/100 | $238M | 58 mo ago | 105 | Brendan Frey Co-Founder & Chief Innovation Officer | WagtailPythonDjango+9 | 92 patents AI-driven genomic variant analysis and therapeutic design for precision medicine | 6 job openings · 1 expansion |
| 3 | Cybin Provider of psychedelic therapeutics for psychiatric disorders 55Funding top 15%Tech top 42%Talent top 45%Moat top 48% All 6 signals ▾Fundingtop 15% Techtop 42% Talenttop 45% Moattop 48% Marketbottom 47% Globalbottom 37% Funding: Raised $230M across 6 rounds · 6 rounds over 6 yrs (1.0/yr) Tech: 34 technologies across 4/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 55/100 | $230M | 11 mo ago | 50 | Aaron Bartlone COO | BugHerdQ4MediaElement.js+17 | — | — |
| 4 | Benchsci Developer of an AI platform for understanding disease biology 78AI top 20%Funding top 25%Talent top 28%Moat top 31% All 11 signals ▾AItop 20% Fundingtop 25% Talenttop 28% Moattop 31% Techtop 32% Innovationtop 35% Producttop 37% Markettop 45% Growthtop 45% Globalbottom 37% Newsbottom 32% AI: Classified as an AI company Funding: Raised $170M across 7 rounds · 7 rounds over 10 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 78/100 | $170M | 36 mo ago | 426 | Elvis Wianda Co-Founder | HubSpot CMS HubSalesforceFacebook Login+20 | — | 1 launch |
| 5 | Titan Medical Developer of robotic surgical systems | $142M | 63 mo ago | 48 | — | WordPressMySQLPHP+11 | — | — |
| 6 | Reunion Neuroscience Developer of therapeutics for mental health conditions | $103M | 29 mo ago | 18 | — | WordPressMySQLPHP+17 | 12 patents Design of tryptamine prodrugs and benzyltryptamine derivatives for CNS drug delivery | — |
| 7 | Notch Therapeutics Developer of stem-cell derived immune cell therapies | $100M | 25 mo ago | 90 | Shreya Shukla Founder | WordPressApple iCloud MailMySQL+18 | 18 patents Engineered T‑cell immunotherapies from stem cells and AI‑driven cellular outcome prediction | — |
| 8 | Synaptive Medical Planning and imaging solutions for neurosurgery 74Patents top 20%Funding top 23%Product top 25%Moat top 26% All 11 signals ▾Patentstop 20% Fundingtop 23% Producttop 25% Moattop 26% Innovationtop 31% Growthtop 35% Talenttop 38% Techtop 41% Markettop 43% Globaltop 45% Newsbottom 21% Patents: 730 patents matched (strict assignee match) · 264 filings since 2022 vs 378 in 2017-21 Funding: Raised $76.8M across 12 rounds · 12 rounds over 12 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 74/100 | $77M | 11 mo ago | 200 | Cameron Piron Co-Founder | WordPressApple iCloud MailMySQL+19 | 730 patents Patents concentrated in health & consumer products | — |
| 9 | Aptose Biosciences Targeted small molecules for the treatment of acute myeloid leukemia and high-risk myelodysplastic syndromes. | $52M | 28 mo ago | 31 | — | anime.jsBootstrapApache HTTP Server+12 | 69 patents Patents concentrated in health & consumer products | — |
| 10 | Venus Developer of medical aesthetic devices for clinics | $47M | 36 mo ago | — | Rajiv Desilva Chief Executive Officer | DudaSalesforceNginx+27 | — | 2 launchs |
| 11 | Radiant Biotherapeutics Developer of therapeutics for cancer, auto-immune and infectious diseases 37Patents top 33%Funding top 34%Moat top 38%Innovation top 40% All 9 signals ▾Patentstop 33% Fundingtop 34% Moattop 38% Innovationtop 40% Techtop 41% Growthbottom 47% Globalbottom 40% Marketbottom 26% Newsbottom 18% Patents: 38 patents matched (strict assignee match) · 38 filings since 2022 vs 0 in 2017-21 Funding: Raised $43.0M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 37/100 | $43M | 21 mo ago | 11 | — | WordPress Block EditorWordPressMySQL+16 | 38 patents Multispecific antibody therapeutics targeting TNF receptors and cytokine pathways | — |
| 12 | ACTO Provider of an AI and SaaS-based educational platform for the life science industry 40Funding top 29%Growth top 37%Moat top 39%Product top 40% All 7 signals ▾Fundingtop 29% Growthtop 37% Moattop 39% Producttop 40% Techtop 48% Globalbottom 43% Marketbottom 29% Funding: Raised $39.5M across 3 rounds · 3 rounds over 6 yrs (0.5/yr) Growth: 1 acquisition/expansion move in 24 mo · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 40/100 | $40M | 21 mo ago | 18 | — | WordPressMySQLPHP+28 | — | — |
| 13 | Flosonics Medical Developer of non-invasive hemodynamic monitoring devices 48Funding top 29%Moat top 32%Product top 35%Patents top 39% All 9 signals ▾Fundingtop 29% Moattop 32% Producttop 35% Patentstop 39% Innovationtop 42% Techtop 44% Globalbottom 43% Marketbottom 39% Newsbottom 22% Funding: Raised $39.0M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) Moat: Editorial + unicorn rating 7/10 · IP moat: 22 patents rank vs industry peers · Fliar Intelligence Index 48/100 | $39M | 15 mo ago | 38 | — | WordPressApple iCloud MailGoogle Workspace+37 | 22 patents Wearable ultrasound flow sensing patches and dynamic fluid control systems for medical applications | 2 job openings · 2 awards |
| 14 | Tetra Bio-Pharma Developer of natural medicinal plant-based elements for treating multiple diseases 32Funding top 26%Talent bottom 49%Market bottom 41%Tech bottom 38% All 6 signals ▾Fundingtop 26% Talentbottom 49% Marketbottom 41% Techbottom 38% Globalbottom 36% Newsbottom 24% Funding: Raised $37.9M across 7 rounds · 7 rounds over 8 yrs (0.9/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 32/100 | $38M | 39 mo ago | 33 | Andre Audet Co-Founder | — | — | — |
| 15 | Helix BioPharma Developer of therapies for the treatment and prevention of cancer 35Product top 14%Moat top 28%Funding top 34%Patents top 38% All 11 signals ▾Producttop 14% Moattop 28% Fundingtop 34% Patentstop 38% Innovationtop 44% Techtop 47% Talentbottom 49% Growthbottom 47% Newsbottom 43% Globalbottom 43% Marketbottom 23% Product: 5 distinct product lines · Company stage: Public Moat: Editorial + unicorn rating 5/10 · IP moat: 110 patents rank vs industry peers · Fliar Intelligence Index 35/100 | $36M | 9 mo ago | 7 | Jacek Antas Ceo & Chairman Of The Executive Board | WordPressMySQLPHP+23 | 110 patents Engineered immune‑cell and antibody‑enzyme therapeutics for tumor microenvironment modulation | — |
| 16 | Sernova Regenerative medicine to deliver proteins and hormones for disease treatment 37Funding top 24%Talent top 28%Moat top 38%Patents top 41% All 10 signals ▾Fundingtop 24% Talenttop 28% Moattop 38% Patentstop 41% Newstop 46% Innovationbottom 45% Globalbottom 43% Growthbottom 40% Marketbottom 37% Techbottom 36% Funding: Raised $32.5M across 28 rounds · 28 rounds over 25 yrs (1.1/yr) Talent: Analyst team rating 4/5 rank vs industry peers · Fliar Intelligence Index 37/100 | $32M | 7 mo ago | 21 | — | WordPressMySQLPHP+13 | 66 patents Patents concentrated in health & consumer products | 1 launch |
| 17 | Exact Imaging Developer of micro-ultrasound based imaging device 45Funding top 28%Moat top 32%Growth top 35%Patents top 46% All 9 signals ▾Fundingtop 28% Moattop 32% Growthtop 35% Patentstop 46% Talentbottom 49% Innovationbottom 47% Techbottom 44% Globalbottom 42% Marketbottom 39% Funding: Raised $29.9M across 5 rounds · 5 rounds over 13 yrs (0.4/yr) Moat: Editorial + unicorn rating 7/10 · IP moat: 45 patents rank vs industry peers · Fliar Intelligence Index 45/100 | $30M | 4 mo ago | 32 | Randy Aucoin President & CEO | ExpressionEnginePHPSalesforce+19 | 45 patents High‑resolution ultrasound imaging and needle‑guidance systems for interventional diagnostics | — |
| 18 | Conavi A catheter-based ultrasound system for cardiac imaging 48Funding top 24%Growth top 38%News top 38%Partners top 40% All 9 signals ▾Fundingtop 24% Growthtop 38% Newstop 38% Partnerstop 40% Moattop 48% Talentbottom 49% Marketbottom 48% Techbottom 41% Globalbottom 29% Funding: Raised $27.7M across 5 rounds · 5 rounds over 7 yrs (0.7/yr) Growth: 2 acquisition/expansion moves in 24 mo · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 48/100 | $28M | 5 mo ago | 76 | Aman Thind Co-founder and Chief Technology Officer | YouTubeGoogle Cloudstyled-components+6 | — | 1 launch · 2 awards |
| 19 | MedX Health Developer of skin analysis and assessment systems 32Funding top 36%Moat top 38%Tech top 39%Growth bottom 47% All 9 signals ▾Fundingtop 36% Moattop 38% Techtop 39% Growthbottom 47% Patentsbottom 45% Innovationbottom 44% Globalbottom 38% Newsbottom 33% Marketbottom 28% Funding: Raised $21.3M across 21 rounds · 21 rounds over 10 yrs (2.1/yr) Moat: Editorial + unicorn rating 5/10 · IP moat: 15 patents rank vs industry peers · Fliar Intelligence Index 32/100 | $21M | 4 mo ago | 16 | — | Cart FunctionalitySquarespace CommerceSquarespace+24 | 15 patents Patents concentrated in health & consumer products | 3 launchs |
| 20 | Revive Therapeutics Developer of therapeutics to treat rare and infectious diseases 27Product top 24%Moat top 32%Funding top 36%Patents top 42% All 10 signals ▾Producttop 24% Moattop 32% Fundingtop 36% Patentstop 42% Innovationtop 44% Growthtop 48% Techbottom 48% Newsbottom 43% Globalbottom 31% Marketbottom 16% Product: 2 distinct product lines · Company stage: Public Moat: Editorial + unicorn rating 5/10 · IP moat: 24 patents rank vs industry peers · Fliar Intelligence Index 27/100 | $17M | 10 mo ago | 3 | — | WordPressMySQLPHP+16 | 24 patents Neuroprotective and anti‑infective therapeutics repurposing bucillamine and psilocybin | — |
| 21 | MolecuLight Provider of point of care device for wound assessment | $16M | 17 mo ago | 49 | — | WordPressApple iCloud MailMicrosoft 365+30 | 77 patents Point‑of‑care fluorescence and multimodal medical imaging devices with AI analysis | 1 launch |
| 22 | Grey Matter Neurosciences Developer of medical devices for neurological disease treatment | $14M | 16 mo ago | — | Jeffrey Coull Founder & CEO | WordPressMySQLPHP+17 | — | — |
| 23 | Profound Medical Developer of image guided prostate ablation system for cancer treatment 80Patents top 25%Funding top 31%Innovation top 33%Tech top 34% All 12 signals ▾Patentstop 25% Fundingtop 31% Innovationtop 33% Techtop 34% Moattop 35% Growthtop 36% Newstop 39% Markettop 40% Fin. healthtop 41% Globaltop 44% AItop 45% Partnerstop 45% Patents: 171 patents matched (strict assignee match) · 60 filings since 2022 vs 85 in 2017-21 Funding: Raised $12.9M across 11 rounds · 11 rounds over 18 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 80/100 | $13M | 5 mo ago | 131 | — | WordPressMySQLPHP+27 | 171 patents Patents concentrated in health & consumer products | — |
| 24 | Virica Biotech Developer of viral sensitizer technology therapeutics to treat viral infections | $12M | 25 mo ago | 29 | Jean Diallo Founder & CEO | WordPressMySQLPHP+31 | 4 patents Enhancing viral vector production using kinase inhibitor-based bioprocess methods. | 1 launch · 1 partnership |
| 25 | Intrepid Labs Developer of drug formulation science to accelerate the development of therapeutics 35Market bottom 49%Funding bottom 49%Talent bottom 49%Global bottom 45% All 4 signals ▾Marketbottom 49% Fundingbottom 49% Talentbottom 49% Globalbottom 45% Funding: Raised $11.0M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 35/100 | $11M | 13 mo ago | — | Christine Allen Co-Founder and CEO | — | — | — |
| 26 | Intellijoint Developer of 3D surgical navigation tools for hip and knee replacements 50Growth top 35%Funding top 38%Tech top 50%Talent bottom 49% All 7 signals ▾Growthtop 35% Fundingtop 38% Techtop 50% Talentbottom 49% Marketbottom 48% Moatbottom 38% Globalbottom 36% Growth: Fresh capital in last 24 mo Funding: Raised $11.0M across 4 rounds · 4 rounds over 12 yrs (0.3/yr) rank vs industry peers · Fliar Intelligence Index 50/100 | $11M | 16 mo ago | 125 | Armen Bakirtzian Co-Founder and CEO | WordPressApple iCloud MailGoogle Workspace+27 | — | 2 partnerships |
| 27 | VentriPoint Heart analysis system 62News top 18%Product top 24%Growth top 25%Partners top 32% All 10 signals ▾Newstop 18% Producttop 24% Growthtop 25% Partnerstop 32% Fundingtop 36% Globaltop 37% Techtop 44% Innovationtop 47% Moattop 48% Marketbottom 45% News: 9 BI events in 12 mo (of 46 tracked, 7 types) · +350% YoY Product: 1 product launch event in 12 mo · 12 distinct product lines rank vs industry peers · Fliar Intelligence Index 62/100 | $9M | 16 mo ago | — | — | WordPressMySQLZoho+17 | — | — |
| 28 | Cardiol Therapeutics Developer of anti-inflammatory therapies for heart disease 53News top 24%Growth top 25%Patents top 31%Moat top 32% All 11 signals ▾Newstop 24% Growthtop 25% Patentstop 31% Moattop 32% Innovationtop 34% Fundingtop 37% Talentbottom 49% Techbottom 41% Globalbottom 36% Partnersbottom 35% Marketbottom 33% News: 16 BI events in 12 mo (of 39 tracked, 6 types) · +129% YoY Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 53/100 | $9M | 8 mo ago | 17 | David Elsley President & CEO/Founder | WordPressApple iCloud MailMicrosoft 365+19 | 55 patents Cannabinoid-based cardiovascular therapies and polymeric drug‑delivery formulations for heart disease | 1 award |
| 29 | Psyence Developer of psychedelic therapeutics for mental health disorders 45News top 26%Growth top 36%Funding top 40%Global top 41% All 7 signals ▾Newstop 26% Growthtop 36% Fundingtop 40% Globaltop 41% Talenttop 49% Marketbottom 43% Techbottom 36% News: 10 BI events in 12 mo (of 25 tracked, 10 types) · +25% YoY Growth: Web rank 10,000,000 → 50,000,000 YoY · 3 acquisition/expansion moves in 24 mo rank vs industry peers · Fliar Intelligence Index 45/100 | $9M | 12 mo ago | — | Alan Friedman Co-Founder | WordPressMySQLPHP+22 | — | — |
| 30 | Illumisonics Developer of photoacoustic remote sensing microscopy solutions for tissue imaging | $7M | 15 mo ago | 17 | Parsin Haji Reza Founder | — | 83 patents Non‑invasive photoacoustic and photon‑absorption imaging for tissue diagnostics | 4 launchs |
| 31 | Paradox Immunotherapeutics Developer of immunotherapeutics for the treatment of rare diseases | $7M | 15 mo ago | 9 | Yulong Sun Co-Founder | — | 5 patents Therapeutic monoclonal antibodies targeting conformational epitopes of lambda immunoglobulin light chains | — |
| 32 | Edesa Biotech Developer of topical therapeutics for dermatological and gastrointestinal diseases | $7M | 16 mo ago | 16 | Par Nijhawan Founder & CEO | WordPressMySQLPHP+16 | 8 patents Peptide-based therapeutics for vitiligo and acute respiratory distress syndrome treatment | — |
| 33 | Pattern Pharma Developer of immunotherapies to treat cancers and infectious diseases | $7M | 14 mo ago | 5 | — | — | — | — |
| 34 | BirchBioMed Developer of anti-scarring drugs and autoimmune therapies | $6M | 11 mo ago | 6 | — | — | 16 patents Topical small‑molecule anti‑aging and scar‑reduction dermatology formulations | — |
| 35 | Telo Genomics Developer of non-invasive prognostic and diagnostic applications that improve disease treatment 37Moat top 31%News top 38%Talent top 39%Partners top 40% All 11 signals ▾Moattop 31% Newstop 38% Talenttop 39% Partnerstop 40% Patentstop 43% Fundingtop 44% AItop 45% Growthtop 48% Innovationbottom 48% Globalbottom 33% Marketbottom 24% Moat: Editorial + unicorn rating 6/10 · IP moat: 9 patents News: 9 BI events in 12 mo (of 37 tracked, 6 types) · -25% YoY rank vs industry peers · Fliar Intelligence Index 37/100 | $5M | 3 mo ago | 6 | Sherif Louis CEO | — | 9 patents Diagnostic assays for smoldering multiple myeloma using nucleic‑acid biomarkers | — |
| 36 | SpinaFX Medical Provider of minimally invasive oxygen-ozone therapy for herniated discs | $5M | 17 mo ago | 7 | Jeff Cambra CEO | — | — | — |
| 37 | Theralase Technologies Super pulsed cold laser technology for musculoskeletal pain | $5M | 19 mo ago | 14 | Roger Dumoulin-White President and Chief Executive Officer | WordPressTypeScriptPHP+40 | 6 patents Patents concentrated in chemistry & materials | — |
| 38 | ProteinQure Provider of computational protein drug design platform 53Talent top 28%AI top 30%Innovation top 36%Product top 36% All 10 signals ▾Talenttop 28% AItop 30% Innovationtop 36% Producttop 36% Moattop 37% Patentstop 38% Fundingtop 46% Techbottom 45% Globalbottom 40% Marketbottom 29% Talent: Analyst team rating 4/5 · 4 named leaders on record AI: Classified as an AI company · Product described with: artificial intelligence rank vs industry peers · Fliar Intelligence Index 53/100 | $4M | 12 mo ago | 18 | Tomas Babej Cofounder and Chief Technology Officer | WordPressProton MailApple iCloud Mail+13 | 9 patents Protein therapeutics targeting the sortilin receptor and natriuretic peptide delivery systems | 2 job openings |
| 39 | HDAX Developer of small molecule drugs to treat cancer and CNS disorders | $3M | 21 mo ago | 8 | Pimyupa Manaswiyoungkul Co-Founder & COO | WordPressMySQLPHP+22 | — | — |
| 40 | MyndTec Developer of functional electrical stimulation therapy for upper limb paralysis 11Funding top 34%Moat top 38%Talent bottom 45%Global bottom 40% All 7 signals ▾Fundingtop 34% Moattop 38% Talentbottom 45% Globalbottom 40% Patentsbottom 38% Marketbottom 24% Innovationbottom 19% Funding: Raised $3.2M across 13 rounds · 13 rounds over 15 yrs (0.9/yr) Moat: Editorial + unicorn rating 4/10 · IP moat: 17 patents rank vs industry peers · Fliar Intelligence Index 11/100 | $3M | 4 mo ago | 11 | Milos Popovic Co-founder and Director | — | 17 patents Implantable neurostimulation devices with wireless telemetry for functional electrical therapy | — |
| 41 | Esphera SynBio Developer of cancer and immunoregulatory treatments using synthetic biology 45Talent top 28%Funding top 45%Global bottom 33% All 3 signals ▾Talenttop 28% Fundingtop 45% Globalbottom 33% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Funding: Raised $2.4M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 45/100 | $2M | 1 mo ago | — | John Bell Co-Founder | — | — | — |
| 42 | VAE Labs Internet-first brand offering energy sprays | $2M | 17 mo ago | 5 | Chaim Weinerman Founder | — | — | — |
| 43 | Proteocyte Provider of diagnostic test to predict risk of developing cancers | $2M | 13 mo ago | 5 | — | Cart FunctionalityWordPressMySQL+22 | — | 2 launchs |
| 44 | Lactiga Developer of immunotherapies to treat infectious diseases | $2M | 16 mo ago | 5 | Viraj Mane Co-Founder | — | 8 patents Polyclonal antibody therapeutics for RSV and oral breast‑milk‑derived immunoglobulin delivery | — |
| 45 | Steadiwear Designer & manufacturer of healthcare gloves 29Growth top 35%Moat top 38%Tech top 42%Funding bottom 49% All 10 signals ▾Growthtop 35% Moattop 38% Techtop 42% Fundingbottom 49% Talentbottom 49% Productbottom 47% Innovationbottom 40% Globalbottom 39% Patentsbottom 37% Marketbottom 17% Growth: Fresh capital in last 24 mo Moat: Editorial + unicorn rating 4/10 · IP moat: 8 patents rank vs industry peers · Fliar Intelligence Index 29/100 | $1M | 8 mo ago | 6 | Mark Elias Co-Founder & CEO | ShopifyShop PayPayPal+32 | 8 patents Wearable tremor‑damping devices for involuntary hand motion control in medical applications | — |
| 46 | EMN Developer of clinical-grade nutrition products | $1M | 17 mo ago | 10 | Timothy Ormond Co-Founder | Cart FunctionalitySquarespace CommerceSquarespace+14 | — | 1 launch |
| 47 | Ostia Sciences Developer of microbes for fighting infectious diseases and enhancing immune function | $740K | 11 mo ago | — | Michael Glogauer Co-Founder | — | — | — |
| 48 | Quantum Biopharma Developer of therapies for neurodegenerative and neuropsychiatric diseases | $500K | 7 mo ago | — | Anthony Durkacz Co-Founder | DudaYouTubeReact+16 | — | 1 launch |
| 49 | Clincove AI-powered clinical trial management platform designed to streamline and accelerate Phase I–III studies 40AI top 45%Talent top 45%Funding bottom 41%Global bottom 33% All 4 signals ▾AItop 45% Talenttop 45% Fundingbottom 41% Globalbottom 33% AI: Product described with: ai-powered Talent: 2 named leaders on record rank vs industry peers · Fliar Intelligence Index 40/100 | $500K | 8 mo ago | — | Michael Sousa Chief Technology Officer | — | — | 2 launchs |
| 50 | StokedBio Developer of therapeutics based on AI technology 45Talent top 28%AI top 45%Funding top 46%Market bottom 37% All 5 signals ▾Talenttop 28% AItop 45% Fundingtop 46% Marketbottom 37% Globalbottom 29% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated AI: Product described with: ai-based rank vs industry peers · Fliar Intelligence Index 45/100 | $366K | 1 mo ago | — | Chris Sinclair Co-Founder | — | — | — |
Top 12 Life Sciences companies in Ontario
#1
Public · Toronto, Ontario · founded 2004 · 7 employees$247.3Mraised▾
Public · Toronto, Ontario · founded 2004 · 7 employees
ProMIS Neurosciences discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment of neurodegenerative diseases, in particular, Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS). The company utilizes its computational discovery platform, ProMIS, to predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins. It owns the exclusive rights to the Genus patent relating to misfolded SOD1 in ALS, and currently has a preclinical monoclonal antibody therapeutic directed against this target.
Fliar Intelligence Index™ 37how this company ranks against its industry peers
Funding
top 10%Patents
top 38%Moat
top 38%Talent
top 38%News
top 42%Innovation
top 47%Funding: Raised $247M across 37 rounds · 37 rounds over 20 yrs (1.9/yr) · Last round Post IPO (Jan 2026)
Patents: 78 patents matched (strict assignee match) · 29 filings since 2022 vs 39 in 2017-21 · Latest publication 2026
Moat: Editorial + unicorn rating 5/10 · IP moat: 78 patents · 10 curated direct competitors tracked
Audience (LinkedIn): 3k LinkedIn followers
Funding rounds
- Jan 2026Post IPO$175M
- Jul 2025Post IPO$9.2M
- Sep 2023Post IPO$14.9M
- Oct 2022Post IPO$7.5M
Founders & team
Investors
The Kraft Group, Nosterra, Ally Bridge Group, Janus Henderson Investors, Deep Track Capital, Great Point Partners
Tech stack
Apache Http ServerBootstrapFancyboxGodaddyGoogle AnalyticsHcaptcha
#2
Public · Toronto, Ontario · founded 2002 · 50 employees$229.7Mraised▾
Public · Toronto, Ontario · founded 2002 · 50 employees
Provider of psychedelic therapeutics for psychiatric disorders. The product pipeline includes CYB003 a deuterated psilocin for the adjunctive treatment of major depressive disorderCYB004 deuterated dimethyltryptamine compound targeting generalized anxiety disorder and CYB005 aphenethylamine derivative treating neuroinflammation.
Fliar Intelligence Index™ 55how this company ranks against its industry peers
Funding
top 15%Tech
top 42%Talent
top 45%Moat
top 48%Market
bottom 47%Global
bottom 37%Funding: Raised $230M across 6 rounds · 6 rounds over 6 yrs (1.0/yr) · Last round Post IPO (Jun 2025)
Tech: 34 technologies across 4/8 capability areas · Cloud: Cloudflare · Devops: Nginx
Talent: 2 named leaders on record · 1 C-suite/founder profile curated
Audience (LinkedIn): 31k LinkedIn followers — 9.2% of this cohort's audience
Funding rounds
- Jun 2025Post IPO$50M
- Mar 2024Post IPO$150M
- Mar 2022Post IPO$317.1K
- Feb 2021Post IPO—
Founders & team
Investors
Deep Track Capital, Hightrailcapital, Noetic Psychedelic Fund, JLS Fund, Innovating Capital, The Conscious Fund
#3
Series D · Markham, Ontario · founded 2013 · 32 employees$29.9Mraised▾
Series D · Markham, Ontario · founded 2013 · 32 employees
Exact Imaging has developed a micro-ultrasound based imaging device. The ExactVu system operates at 29MHz waves for higher resolution and is used for imaging prostate cancer and biopsies. The product has an integrated disposable needle biopsy apparatus for visualization and targeting of suspicious small regions. in real-time
Fliar Intelligence Index™ 45how this company ranks against its industry peers
Funding
top 28%Moat
top 32%Growth
top 35%Patents
top 46%Talent
bottom 49%Innovation
bottom 47%Funding: Raised $29.9M across 5 rounds · 5 rounds over 13 yrs (0.4/yr) · Last round Series D (Feb 2026)
Moat: Editorial + unicorn rating 7/10 · IP moat: 45 patents · 9 curated direct competitors tracked
Growth: Fresh capital in last 24 mo
Audience (LinkedIn): 4k LinkedIn followers
Funding rounds
- Feb 2026Series D$10M
- Aug 2019Series C$244.4K
- Feb 2019Series C$7.6M
- Jan 2017Series C$16.1M
Founders & team
Investors
iGan Partners, Veddis App, MaRS IAF, Lumira Ventures, Vesalius Biocapital Partners, PMV
Tech stack
Adobe Experience Platform LaunchApache Http ServerBootstrapCallrailCloudflareCloudflare Bot Management
#4
Public · Mississauga, Ontario · founded 1999 · 16 employees$21.3Mraised▾
Public · Mississauga, Ontario · founded 1999 · 16 employees
Developer of skin analysis and assessment systems. The company has developed a non-invasive device called SIAscopy technology which utilizes light to view beneath moles and lesions. It includes software that creates real-time images for doctors and dermatologists for evaluating moles and lesions.
Fliar Intelligence Index™ 32how this company ranks against its industry peers
Funding
top 36%Moat
top 38%Tech
top 39%Growth
bottom 47%Patents
bottom 45%Innovation
bottom 44%Funding: Raised $21.3M across 21 rounds · 21 rounds over 10 yrs (2.1/yr) · Last round Post IPO (Feb 2026)
Moat: Editorial + unicorn rating 5/10 · IP moat: 15 patents
Tech: 27 technologies across 4/8 capability areas · Cloud: Cloudflare · Security: Cloudflare Bot Management, Hsts
Audience (LinkedIn): 1k LinkedIn followers
Activity (LinkedIn): 3 product launches announced in 12 mo
Funding rounds
- Feb 2026Post IPO$2M
- Jul 2025Post IPO$387.2K
- Apr 2025Post IPO$671K
- Feb 2025Post IPO$1M
Investors
Agoracom
Tech stack
AngularCart FunctionalityCloudflareCloudflare Bot ManagementCore-JsGodaddy
#5
Public · Toronto, Ontario · founded 2007 · 76 employees$27.7Mraised▾
Public · Toronto, Ontario · founded 2007 · 76 employees
A catheter-based ultrasound system for cardiac imaging. The company has developed, Foresight ICE System, a catheter-based ultrasound system capable of providing both 2D and 3D ultrasound images of cardiac anatomy around the circumference of the catheter's tip.
Fliar Intelligence Index™ 48how this company ranks against its industry peers
Funding
top 24%Growth
top 38%News
top 38%Partners
top 40%Moat
top 48%Talent
bottom 49%Funding: Raised $27.7M across 5 rounds · 5 rounds over 7 yrs (0.7/yr) · Last round Post IPO (Jan 2026)
Growth: 2 acquisition/expansion moves in 24 mo · Fresh capital in last 24 mo
News: 14 BI events in 12 mo (of 41 tracked, 11 types) · -18% YoY · 3 high-value events (IPO/M&A/funding/contracts) in 12 mo
Audience (LinkedIn): 9k LinkedIn followers — 2.7% of this cohort's audience
Activity (LinkedIn): 1 product launches · 2 awards announced in 12 mo
Funding rounds
- Jan 2026Post IPO$700K
- Apr 2025Post IPO$15.5M
- Oct 2024Series B$7.7M
- Dec 2021Series B$20M
Founders & team
Investors
FedDev Ontario, Titan Medical, MaRS Discovery District, CPOINT Capital, Tivona Capital, Ontario Brain Institute
Tech stack
GodaddyGoogle CloudGoogle Cloud CdnGoogle Font ApiHttp/3Open Graph
#6
Public · London, Ontario · founded 1998 · 21 employees$32.5Mraised▾
Public · London, Ontario · founded 1998 · 21 employees
Sernova Corp. is a development stage regenerative medicine company. The Company is focused on commercializing the Cell Pouch, a scalable, implantable, medical device for the transplantation and survival of therapeutic cells, which then release proteins and hormones for the long-term treatment of various diseases, such as diabetes, hemophilia and thyroid disease. The Company is also developing Sertolin, a cell-based technology providing an immune-privileged environment for donor cells, reducing or eliminating the need for anti-rejection drugs. The Company's primary program is the clinical development of the Cell Pouch for the treatment of patients with insulin-dependent diabetes.
Fliar Intelligence Index™ 37how this company ranks against its industry peers
Funding
top 24%Talent
top 28%Moat
top 38%Patents
top 41%News
top 46%Innovation
bottom 45%Funding: Raised $32.5M across 28 rounds · 28 rounds over 25 yrs (1.1/yr) · Last round Post IPO (Oct 2025)
Talent: Analyst team rating 4/5
Moat: Editorial + unicorn rating 5/10 · IP moat: 66 patents · 9 curated direct competitors tracked
Audience (LinkedIn): 5k LinkedIn followers
Activity (LinkedIn): 1 product launches announced in 12 mo
Funding rounds
- Oct 2025Post IPO$344.5K
- Mar 2025Post IPO$694.5K
- Sep 2024Post IPO$473.1K
- Sep 2022Post IPO$3.5M
Investors
Europa, National Research Council Canada, Evotec
Tech stack
Apache Http ServerAstraCore-JsElementorGoogle AnalyticsGoogle Font Api
#7
Series C · Mississauga, Ontario · founded 2012 · 200 employees$76.8Mraised▾
Series C · Mississauga, Ontario · founded 2012 · 200 employees
Synaptive Medical develops planning tools and imaging solutions for application in minimally invasive neurosurgery. Its solutions include BrightMatter Prime which enables thorough and systematic pre-operative preparation with training tools, high fidelity images as well as a smooth and seamless workflow into the surgical suite; and BrightMatter™ Servo which unites high-resolution imaging capabilities with hands-free alignment while seamlessly delivering 3D tractography visualization for navigation into the surgical suite. The company acquired FDA clearance for its product BrightMatter Guide which is a 3D neuro-navigation system.
Fliar Intelligence Index™ 74how this company ranks against its industry peers
Patents
top 20%Funding
top 23%Product
top 25%Moat
top 26%Innovation
top 31%Growth
top 35%Patents: 730 patents matched (strict assignee match) · 264 filings since 2022 vs 378 in 2017-21 · Latest publication 2026
Funding: Raised $76.8M across 12 rounds · 12 rounds over 12 yrs (1.0/yr) · Last round Series C (Jul 2025)
Product: 11 distinct product lines · Company stage: Series C
Audience (LinkedIn): 31k LinkedIn followers — 9.2% of this cohort's audience
Funding rounds
- Jul 2025Series C—
- Mar 2023Conventional Debt$40M
- Oct 2020Series C$17M
- Dec 2019Series C$25M
Founders & team
Investors
Linamar, Export Development Canada, General Atlantic, Sensegain Capital, Sissel Technology Development, Espresso Capital
Tech stack
Apple Icloud MailBootstrapCdnjsCloudflareDropboxGoogle Tag Manager
#8
Public · Toronto, Ontario · founded 2008 · 131 employees$12.9Mraised▾
Public · Toronto, Ontario · founded 2008 · 131 employees
Developer of image guided prostate ablation system for cancer treatment. The company uses proprietary technology and provide TULSA-PRO is an AI-powered, MRI-guided, incision-free robotic ablation system for the ablation of prostate tissue.
Fliar Intelligence Index™ 80how this company ranks against its industry peers
Patents
top 25%Funding
top 31%Innovation
top 33%Tech
top 34%Moat
top 35%Growth
top 36%Patents: 171 patents matched (strict assignee match) · 60 filings since 2022 vs 85 in 2017-21 · Latest publication 2026
Funding: Raised $12.9M across 11 rounds · 11 rounds over 18 yrs (0.6/yr) · Last round Post IPO (Dec 2025)
Innovation: 171 patents (top 16% of patent-holders) · 60 filings since 2022 vs 85 in 2017-21 · Deep-tech classification: Tech Hardware
Audience (LinkedIn): 18k LinkedIn followers — 5.3% of this cohort's audience
Funding rounds
- Dec 2025Post IPO$6.5M
- Jan 2024Post IPO—
- Jul 2020Post IPO$46M
- Mar 2018Post IPO$34.5M
Investors
BDC, Genesys Capital, FedDev Ontario, Knight Therapeutics, Stifel, Cormark Securities
Tech stack
Amazon CloudfrontAmazon Web ServicesApache Http ServerBootstrapChart.JsCloudflare
#9
Public · Aurora, Ontario · founded 1995 · 7 employees$36.2Mraised▾
Public · Aurora, Ontario · founded 1995 · 7 employees
Developer of therapies for the treatment and prevention of cancer. The pipeline candidates include topical interferon - alpha2b, and LDOS47 for the treatment of small-cell lung cancer and pancreatic cancer. The company also has a patented technology platform DOS47 focused on achieving better debilitation of cancer cells.
Fliar Intelligence Index™ 35how this company ranks against its industry peers
Product
top 14%Moat
top 28%Funding
top 34%Patents
top 38%Innovation
top 44%Tech
top 47%Product: 5 distinct product lines · Company stage: Public
Moat: Editorial + unicorn rating 5/10 · IP moat: 110 patents
Funding: Raised $36.2M across 21 rounds · 21 rounds over 9 yrs (2.3/yr) · Last round Post IPO (Aug 2025)
Funding rounds
- Aug 2025Post IPO$1.7M
- Jan 2025Post IPO$2.1M
- Mar 2024Post IPO$1.4M
- Nov 2022Post IPO$3.4M
Founders & team
Investors
Jerzy Wilczewski
Tech stack
Apache Http ServerAutoptimizeBootstrapCloudflareContact Form 7Core-Js
#10
Public · Toronto, Ontario · founded 2011 · 6 employees$5.5Mraised▾
Public · Toronto, Ontario · founded 2011 · 6 employees
Developer of non-invasive prognostic and diagnostic applications that improve disease treatment. The company has a proprietary technology that uses a quantitative analysis of 3D telomeres with molecular biology and artificial intelligence to recognize disease-associated genetic instability. It is developing Telo-MM application to provide e information to medical professionals in the treatment of Multiple Myeloma.
Fliar Intelligence Index™ 37how this company ranks against its industry peers
Moat
top 31%News
top 38%Talent
top 39%Partners
top 40%Patents
top 43%Funding
top 44%Moat: Editorial + unicorn rating 6/10 · IP moat: 9 patents
News: 9 BI events in 12 mo (of 37 tracked, 6 types) · -25% YoY · 4 high-value events (IPO/M&A/funding/contracts) in 12 mo
Talent: 1 named leader on record · 1 C-suite/founder profile curated · 5 leadership moves in 12 mo
Audience (LinkedIn): 845 LinkedIn followers
Funding rounds
- Mar 2026Post IPO—
- Dec 2024Post IPO$1.8M
- May 2023Post IPO$2M
- Jul 2021Post IPO$1.7M
Founders & team
#11
Seed · Ottawa, Ontario · founded 2022$2.4Mraised▾
Seed · Ottawa, Ontario · founded 2022
Developer of cancer and immunoregulatory treatments using synthetic biology. The platform focuses on altering tumor-derived exosomes in vivo such that they become immunostimulatory, antigen-bearing TME and patient-specific cancer vaccines.
Fliar Intelligence Index™ 45how this company ranks against its industry peers
Talent
top 28%Funding
top 45%Global
bottom 33%Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Funding: Raised $2.4M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) · Last round Seed (May 2026)
Global: Single-market focus (Canada)
Audience (LinkedIn): 682 LinkedIn followers
Funding rounds
- May 2026Seed$365.5K
- Jan 2025Seed$2M
- Dec 2024Grant (prize money)—
Founders & team
Investors
FACIT, GKCC, Government of Canada, Ontario Canada
#12
Public · Toronto, Ontario · founded 2012 · 3 employees$16.8Mraised▾
Public · Toronto, Ontario · founded 2012 · 3 employees
Developer of therapeutics to treat rare and infectious diseases. Its lead product Bucillamine (N-(mercapto-2-methylpropionyl)-l-cysteine) helps in treating infectious diseases, including COVID-19, influenza, and others. Also has psilocybin for multiple indications.
Fliar Intelligence Index™ 27how this company ranks against its industry peers
Product
top 24%Moat
top 32%Funding
top 36%Patents
top 42%Innovation
top 44%Growth
top 48%Product: 2 distinct product lines · Company stage: Public
Moat: Editorial + unicorn rating 5/10 · IP moat: 24 patents
Funding: Raised $16.8M across 11 rounds · 11 rounds over 13 yrs (0.8/yr) · Last round Post IPO (Aug 2025)
Audience (LinkedIn): 1k LinkedIn followers
Activity (LinkedIn): 1 product launches announced in 12 mo
Funding rounds
- Aug 2025Post IPO$110.7K
- Apr 2025Post IPO$120.2K
- Jan 2024Post IPO$1.6M
- Jan 2023Post IPO$4.3M
Investors
EMD Financial, Planet Ventures
Tech stack
Apache Http ServerCloudflareCloudflare Bot ManagementDiviGodaddyGoogle Analytics
Funding & investor landscape
$3.9Btotal disclosed funding
213companies funded
736disclosed rounds
2rounds last 90 days
Most active investors
Notable founders
Neil Cashman
Co-Founder · ProMIS Neurosciences
Elliot Goldstein Md
President & CEO · ProMIS Neurosciences
Aaron Bartlone
COO · Cybin
Sarah Hamilton
Director Financial Operations & Strategic Operations · Cybin
Randy Aucoin
President & CEO · Exact Imaging
Aman Thind
Co-founder and Chief Technology Officer · Conavi
Cameron Piron
Co-Founder · Synaptive Medical
Wes Hodges
Co-Founder · Synaptive Medical
Jacek Antas
Ceo & Chairman Of The Executive Board · Helix BioPharma
Sherif Louis
CEO · Telo Genomics
John Bell
Co-Founder · Esphera SynBio
Brian Lichty
Co-Founder & CEO · Esphera SynBio
Prism market signals · Canada · country-scoped Prism corpus, 188,258 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH FROM Ontario · institutions
What Ontario researches in biotechnology
Ontario Institute for Cancer Research and Public Health Ontario lead moderately optimistic biotechnology research (mean stance 0.47), dominated by nanoplatform cancer theranostics and respiratory health themes.
12 papersstance +0.4740% breakthrough20% concern
local research themes
Nanoplatforms for cancer theranosticsNeonatal Respiratory Health ResearchRespiratory viral infections researchNanoparticle-Based Drug DeliveryPolymer Surface Interaction StudiesEffects of Radiation Exposure
top institutions
- Ontario Institute for Cancer Research6
- Public Health Ontario2
- Children\'s Hospital of Eastern Ontario2
- Ontario Tech University1
- Ontario Genomics1
Common questions
How many Life Sciences companies are there in Ontario, Canada?
Radar tracks 674 indexable Life Sciences companies headquartered in Ontario, Canada that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in Ontario, Canada?
The Life Sciences companies in Ontario, Canada on this list have raised a combined $3.9B in disclosed equity funding across 213 funded companies.
Which is the highest-funded Life Sciences company in Ontario, Canada?
ProMIS Neurosciences is the highest-funded Life Sciences company in Ontario, Canada, with $247.3M in disclosed equity funding.
How many Life Sciences companies in Ontario, Canada are funded?
213 of the 674 Life Sciences companies in Ontario, Canada on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in Ontario, Canada?
None of the Life Sciences companies in Ontario, Canada on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Ontario, Canada Life Sciences companies?
The most active investors in Ontario, Canada Life Sciences companies on this list include Ontario Centre of Innovation, Ontario Brain Institute, UTEST, Accelerator Centre, Velocity.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.